维普期刊资源整合服务平台（V6.5）

73篇 您的检索式：作者名="Obach RS"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Metabolic activation in drug-induced liver injury显示文摘	Leung L Kalgutkar AS Obach RS	2012	Drug Metab Rev2012，44，1：	1
2	The impact of P - glycoprotein on the drug targeted for indications of the central nervous system evaluation using the MDR1A/1B knock out mouse model显示文摘	Doran A Obach RS Smith BJ	2005	Drug Metab Dispos2005，33，：	1
3	Metabolism and disposition of varenicline,a selective alpha4beta2 acetylcholine receptor partial agonist,in vivo and in vitro显示文摘	Obach RS Reed-Hagen AE Krueger SS	2006	Drug Metab Dispos2006，34，1：	1
4	Metabolism and disposition of varenicline,a selective alpha4beta2 acetylcholine receptor partial agonist,in vivo and in vitro显示文摘	Obach RS Reed-Hagen AE Krueger SS	2005	Drug Metab Dispos2005，34，1：	1
5	Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug comt)ounds显示文摘	Obach RS Lombardo F Waters NJ	2008	Drug Metab Dispos2008，36，7：	1
6	Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline,a new therapy for smoking cessation:an in vitro-in vivo study显示文摘	Feng B Obach RS Burstein AH	2008	Clin Pharmacol Ther2008，83，4：	1
7	Impact of parallel pathways of drug elimination and multiple cytochrome P450 involvement on drug-drug interactions: CYP2D6 paradigm 显示文摘	Ito K Hallifax D Obach RS	2005	Drug Metab Dispos2005，33，6：	1
8	Effect of human renal cationic transporter inhibition on the pharmacokinetics of vareniciine,a new therapy for smoking cessation:An in vitro-in vivo study显示文摘	Feng B Obach RS Burstein AH	2008	Clin Pharmacol Ther2008，83，4：	1
9	A hy- brid mixture discriminant analysis random forest computational model for the prediction of volume of distribution of drugs in human显示文摘	Lombardo F Obach RS DiCapua FM	2006	J Med Chem2006，49，7：	1
10	Validated assays for human cytochrome P450 activities显示文摘	Walsky RL Obach RS	2004	Drug Metab Dispos2004，32，6：	1
11	Mechanismbased inactivation of human cytochrome P450 enzymes and the prediction of drug-drag interactions 显示文摘	Obach RS Walsky RL Venkatakrishnan K	2007	Drug Metab and dispos2007，35，2：	1
12	Selectiveinhibition of human cytochrome P4502C8by monte-lukast显示文摘	Walsky RL Obach RS Gaman EA	2005	Drug Metab Dispos2005，33，3：	1
13	Examination of 209 drugs for inhibition of cytochrome P450 2C8显示文摘	WALSKY RL GAMAN EA OBACH RS	2005	J Clin Pharmacol2005，45，1：	1
14	The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data显示文摘	Obach RS Baxter JG ListonTE	1997	J Pharmacology Experimental Therapeutics1997，283，1：	1
15	Se- lective inhibition of human cytochrome P4502C8 by montelukast 显示文摘	Walsky RL Obach RS Gaman EA Gleeson JP Proctor WR	2005	Drug Metab Dispos2005，33，3：	1
16	The impact of P - glycoprotein on the disposition of drugs targeted for indications of the central nervous system : evaluation using the MDR1A/1B knockout mouse model 显示文摘	Doran A Obach RS Smith BJ	2005	Drug Metab Dispos2005，33，：	1
17	Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes 显示文摘	Obach RS	1999	Drug Metab Dispos1999，27，：	1
18	The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions显示文摘	Obach RS Walsky RL Venkatakrishnan K	2006	J Pharmacol Exp Ther2006，316，1：	1
19	In vitro cytoehrome P450 inhibition data and the prediction of Drug-drug interactions: Qualitative relationships, quantitative predictions, and the rank-order approach 显示文摘	Obach RS Walsky RL Venkatakrishnan K	2005	Clin Pharmacol Ther2005，78，6：	1
20	Drug metabolism and drug interactions: application and clinical value of in vitro models 显示文摘	VENKATAKRISHNAN K VON MOLTKE LL OBACH RS	2003	Curr Drug Metab2003，4，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示